NLRP3 and hepatocellular carcinoma: Research by Li et al. determined that the anticancer effects of scopolamine could inhibit HCC cell growth and motility, induce apoptosis, and maintain Th1/Th2 balance by suppressing NLRP3 inflammatory vesicle expression and thus NLRP3 inflammatory vesicle activation [39].